Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTDon't just protect. Triple protect.Replace two products with one convenient monthly chew. + See the difference